Emilia Caselli

Associate Professor

University of Modena and Reggio Emilia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Emilia Caselli is an Associate Professor at the Università degli Studi di Modena e Reggio Emilia, Italy. Her research focuses on antibiotic discovery, with recent work emphasizing boronate-based inhibitors and their potential against multidrug-resistant pathogens. Dr. Caselli's contributions include novel designs to combat β-lactamase enzymes and insights into infection resistance mechanisms.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Alfonso Zambon

University of Modena and Reggio Emilia

ITALY

View details

Akiko SHIMIZU-IBUKA

Kanagawa University

JAPAN

View details

Bradley J. Wallar

Grand Valley State University

UNITED STATES

View details

Paolo Zardi

Assistant Professor

University of Padua

ITALY

View details

Brian Luna, PhD

Assistant Professor

University of Southern California Keck School of Medicine

UNITED STATES

View details

Fabio Prati

Full professor

University of Modena and Reggio Emilia

ITALY

View details

Francesco Fini

Associate Professor

University of Modena and Reggio Emilia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emilia Caselli

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Boronate-Based Inhibitors of Penicillin-Binding Proteins: An Underestimated Avenue for Antibiotic Discovery?

Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry

Restoring cefepime activity against multidrug-resistant KPC-producing <i>Klebsiella pneumoniae</i> by combination with boronic acid inhibitors, MB076 and S02030

α‐ Triazolylboronic acids: a novel scaffold to target FLT3 in AML

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates

Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in <i>Acinetobacter baumannii</i>

Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits <i>Acinetobacter</i>-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum

Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in <i>Pseudomonas</i> -derived cephalosporinase

Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses

Straightforward synthesis of chiral non-racemic α-boryl isocyanides

Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor.

1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase

The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm

Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog

A comprehensive and contemporary "snapshot" of β-lactamases in carbapenem resistant Acinetobacter baumannii.

α‐Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs

Structures of FOX-4 Cephamycinase in Complex with Transition-State Analog Inhibitors

Collaborators (7)

Alfonso Zambon

Akiko SHIMIZU-IBUKA

Bradley J. Wallar

Paolo Zardi

Brian Luna, PhD

Fabio Prati

Francesco Fini

Make your next move.